Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Human Vaccines & Immunotherapeutics|May 24, 2017
A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza controlRiju Ray, Gaël Dos Santos, Philip O Buck, et al.Mayo Clinic Proceedings|March 9, 2025
Population-Based Incidence of Infectious Mononucleosis and Related Hospitalizations: 2010 Through 2021Jennifer L St Sauver, Robert M Jacobson, Susan A Weston, et al.Human Vaccines & Immunotherapeutics|June 2, 2016
Estimated incidence of pertussis in people aged <50 years in the United StatesChi-Chang Chen, Catherine Balderston McGuiness, Girishanthy Krishnarajah, et al.Journal of Medical Economics|October 3, 2022
The potential clinical impact of implementing different COVID-19 boosters in fall 2022 in the United StatesMichele A Kohli, Michael Maschio, Amy Lee, et al.BMC Pulmonary Medicine|July 15, 2016
Burden of asthma with elevated blood eosinophil levelsJulian Casciano, Jerry A Krishnan, Mary Buatti Small, et al.Journal of the American Pharmacists Association : Japha|December 11, 2021
Factors influencing series completion rates of recombinant herpes zoster vaccine in the United States: A retrospective pharmacy and medical claims analysisBrandon J Patterson, Chi-Chang Chen, Catherine B McGuiness, et al.BMC Pulmonary Medicine|July 31, 2016
Value of peripheral blood eosinophil markers to predict severity of asthmaJulian Casciano, Jerry A Krishnan, Mary Buatti Small, et al.Vaccines|October 26, 2021
Vaccinating Adolescents and Children Significantly Reduces COVID-19 Morbidity and Mortality across All Ages: A Population-Based Modeling Study Using the UK as an ExampleTinevimbo Shiri, Marc Evans, Carla A Talarico, et al.Vaccines|February 26, 2022
The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose ProgramTinevimbo Shiri, Marc Evans, Carla A Talarico, et al.Human Vaccines & Immunotherapeutics|January 10, 2019
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine liveDesmond Curran, Brandon J Patterson, Desiree Van Oorschot, et al.Pageof 6